Journals / Türkiye Acil Tıp Dergisi / 2007 / Cilt: 7 - Sayı: 3

Propafenone overdose: Two case reports

Propafenon aşırı alımı: Olgu sunumu

Pages
127–131
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this case report, we aimed to overview the complications of propafenone intoxication by presenting two cases of propafenone overdose which seen rarely in the medical literature and to perform literature review on propafenone overdose.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Propafenone is first synthesized in 1970 and its active metabolite is 5-OH-propafenon.
📊
Key Findings & Data:Propafenone is classified as a IC antiarrhythmic drug according to the Vaughan Williams classification and used in the treatment of supraventricular and ventricular tachyarrhythmias.
💡
Conclusion & Impact:In this case report, we aimed to overview the complications of propafenone intoxication by presenting two cases of propafenone overdose which seen rarely in the medical literature and to perform literature review on propafenone overdose.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Propafenone is first synthesized in 1970 and its active metabolite is 5-OH-propafenon. Propafenone is classified as a IC antiarrhythmic drug according to the Vaughan Williams classification and used in the treatment of supraventricular and ventricular tachyarrhythmias. Acute propafenone overdoses typically cause wide QRS tachycardia, right bundle branch block, first degree AV block, prolonged QT interval, hypotension and generalized seizures. Despite the widespread usage of propafenone as an antiaritmic drug, fatal propafenone overdoses have been reported rarely in medical literature. In this case report, we aimed to overview the complications of propafenone intoxication by presenting two cases of propafenone overdose which seen rarely in the medical literature and to perform literature review on propafenone overdose.

Özet

Propafenon etken maddesi 5-OH-propafenon olan ve ilk kez 1970 yılında sentez edilen bir ilaçtır. Propafenon son yıllarda klinik pratiğimizde supraventriküler ve ventriküler taşiaritmilerin tedavisinde çok sık olarak kullanılmaya başlanan Vaughan Williams sınışamasına göre IC alt grubu antiaritmik bir ilaçtır. Akut propafenon aşırı alımında tipik olarak geniş kompleks taşikardi, sağ dal bloğu, birinci derece AV blok ve uzamış QT mesafesi, hipotansiyon ile jeneralize nöbetler görülebilir. Propafenon sık kullanılan antiaritmik bir ilaç olmasına rağmen literatürde ölümcül akut propafenon aşırı alımı olguları çok nadir olarak tanımlanmıştır. Bizim amacımız, literatürde az sayıda bildirilen ölümcül ve ciddi komplikasyonlar ile karşımıza çıkabilen propafenon aşırı alımı olan iki olguyu incelemek ve propafenon aşırı alımı ile ilgili olarak literatürü gözden geçirmektir.

🔖

Cite This Article

YİĞİT, Ö., BEKTAŞ, F., SÖYÜNCÜ, S. (2022). Propafenone overdose: Two case reports. Türkiye Acil Tıp Dergisi, Cilt: 7 - Sayı: 3, 127–131. https://ajindex.com/articles/626169

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Ledda F, Mantelli L, Manzini S, Amerini S, Mugelli A. Electrophysiological and antiarrhythmic properties of propafenon in isolated cardiac preparations. J Cardiovasc Pharmacol 1981;3:1162-73
  2. Vaughan Williams EM. Relevance of cellular to clinical electrophysiology in interpreting antiarrhythmic drug action. Am J Cardiol 1989;64:5J-9J
  3. Siddoway LA, Thompson KA, McAllister CB, Wang T, Wilkinson GR, Roden DM, et al. Polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequences. Circulation 1987;75:785-91
  4. Faber TS, Camm AJ. The differentiation of propafenone from other class Ic agents, focusing on the effect on ventricular response rate attributable to its beta-blocking action. Eur J Clin Pharmacol 1996;51:199-208
  5. Kerns W 2nd, English B, Ford M. Propafenone overdose. Ann Emerg Med 1994;24:98-103
  6. Rambourg-Schepens MO, Grossenbacher F, Buffet M, Lamiable D. Recurrent convulsions and cardiac conduction disturbances after propafenone overdose. Vet Hum Toxicol 1999;41:153-4
  7. Clarot F, Goullé JP, Horst M, Vaz E, Lacroix C, Proust B. Fatal propafenone overdoses:case reports and a review of the literature. J Anal Toxicol 2003;27:595-9
  8. Palette C, Maroun N, Gaulier JM, Priolet B, Lachatre G, Bedos JP, et al. Fatal poisoning with propafenone: a case report documented with blood concentration levels. [Article in French] Therapie 2003;58:384-6; discussion 387. [Abstract] 9. Maxeiner H, Klug E. Lethal suicidal intoxication with propafenone, after a history of self-inflicted injuries. Forensic Sci Int 1997;89:27-32
  9. Bösche J, Mattern R. Fatal poisoning with the antiarrhythmic agent propafenon.[Article in German] Beitr Gerichtl Med 1980;38:231-4. [Abstract] 11. Lanquetot H, Furet Y, Kerourédan V, Poitrineau O, Hubiche M, Autret E. Fatal poisoning caused by the combination propafenone-amitriptyline; apropos of a case.[Article in French] Agressologie 1988;29:39-42. [Abstract] 12. Kolecki PF, Curry SC. Poisoning by sodium channel blocking agents. Crit Care Clin 1997;13:829-48
  10. Henry JA, Cassidy SL. Membrane stabilising activity: a major cause of fatal poisoning.Lancet 1986;1(8495):1414-7
  11. Köppel C, Oberdisse U, Heinemeyer G. Clinical course and outcome in class IC antiarrhythmic overdose. J Toxicol Clin Toxicol 1990;28:433-44
  12. Cocozzella D, Curciarello J, Corallini O, Olivera A, Alburquerque MM, Fraquelli E, et al. Propafenone hepatotoxicity: report of two new cases. Dig Dis Sci 2003;48:354-7.